tiprankstipranks
Supernus Pharmaceuticals (SUPN)
NASDAQ:SUPN
US Market
SUPN
Supernus Pharmaceuticals
RESEARCH TOOLSreports
Want to see SUPN full AI Analyst Report?

Supernus Pharmaceuticals (SUPN) Stock News & Sentiment

531 Followers
Supernus Reaches Milestone, Triggers Contingent Value Rights Payment
Premium
Company Announcements
Supernus Reaches Milestone, Triggers Contingent Value Rights Payment
2d ago
8K
SUPN
SUPN: Buy Rating Reiterated as Strong Growth Supports Unchanged $65 Price Target
Premium
Ratings
SUPN: Buy Rating Reiterated as Strong Growth Supports Unchanged $65 Price Target
17d ago
SUPN
Supernus Pharmaceuticals Earnings Call Signals Growth Momentum
Premium
Company Announcements
Supernus Pharmaceuticals Earnings Call Signals Growth Momentum
17d ago
SUPN
SUPN Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
SUPN Upcoming Earnings Report: What to Expect?
20d ago
SUPN
Supernus Acquires NV-5138 Asset in New Agreement
Premium
Company Announcements
Supernus Acquires NV-5138 Asset in New Agreement
2M ago
8K
SUPN
Supernus Pharmaceuticals Braces for 2025 U.S. Drug Pricing Orders and MFN Rules That Threaten Revenues and Global Expansion
Premium
Company Announcements
Supernus Pharmaceuticals Braces for 2025 U.S. Drug Pricing Orders and MFN Rules That Threaten Revenues and Global Expansion
3M ago
SUPN
Supernus Pharmaceuticals Balances Record Sales With Rising Costs
Premium
Company Announcements
Supernus Pharmaceuticals Balances Record Sales With Rising Costs
3M ago
SUPN
More SUPN News >

SUPN News on the Web

Why Supernus Pharmaceuticals Stock Is Dropping Now
TipRanks News
Neutral
Piper Sandler Reaffirms Their Buy Rating on Supernus Pharmaceuticals (SUPN)
TipRanks News
Bearish
Supernus Acquires NV-5138 Asset in New Agreement
TipRanks News
Neutral
Supernus enters into asset purchase agreement with Navitor
TipRanks News
Neutral
Supernus Pharmaceuticals (SUPN) Gets a Buy from Jefferies
TipRanks News
Bearish
Major Insider Move at Supernus Pharmaceuticals Shakes Up Investor Buzz
TipRanks News
Neutral
Insider Sell Alert: Frederick Hudson Sells Shares of Supernus Pharmaceuticals Inc (SUPN)
GuruFocus News
Bearish
Supernus Pharmaceuticals Inc at Barclays Global Healthcare Conference Transcript
GuruFocus News
Neutral

News Score - Last 7 Days

Very Positive
SUPN
Sector Average
Media Buzz
This Week3 articles
Weekly Average2 articles
News Sentiment
This Week19%
Sector Average78%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is SUPN’s Media Buzz Sentiment?
3 articles about SUPN were published this week. In an average week, 2 articles are published.
    What is SUPN’s weekly average amount of articles?
    In an average week, 2 articles about SUPN are published.
      What is SUPN’s News Sentiment?
      19% of articles about SUPN were positive this week, compared to its sector average of 78%.
        Healthcare Stocks that are Trending in the News
        GOSSGossamer Bio
        RLAYRelay Therapeutics
        ROIVRoivant Sciences
        ILAIsland Pharmaceuticals Ltd
        TLSATiziana Life Sciences
        Showing the stocks with the most bullish news sentiment over the past week